Month: August 2021

Trading Upgrade to OTCQX Best Market and Torrey Hills Capital Engaged MISSISSAUGA, Ontario, Aug. 03, 2021 (GLOBE NEWSWIRE) — Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator and exporter, announces that it has undertaken two actions to improve its profile with United States (U.S.) based investors and to improve its trading liquidity in that market; (i) effective today, achieving qualification to trade on the OTCQX® Best Market under the symbol MBXBF, and (ii) engaged the California-based firm Torrey Hills Capital for U.S. directed investor relations services. The OTCQX® Best Market is for established, investor-focused U.S. and international companies. To qualify for the OTCQX, companies must meet high financial standards, follow best-practices corporate governance, and demonstrate compliance...

CALGARY, Alberta, Aug. 03, 2021 (GLOBE NEWSWIRE) — NXT Energy Solutions Inc. (“NXT” or the “Company”) (TSX:SFD; OTC QB:NSFDF) is pleased to announce it is receiving advisory services and funding of up to $50,000 from the National Research Council of Canada Industrial Research Assistance Program (“NRC IRAP”) to support the research and development of the Stress Field Detection (SFD®) technology for geothermal applications. The objective of this project will be to test, identify and analyze the desired elements of the SFD® geothermal sensor response over known geothermal areas with the ultimate goal of providing a green upstream geophysical service for advancing renewable power initiatives in Canada and abroad. George Liszicasz, President and CEO of NXT Energy, noted, “We are extremely pleased to have support from NRC...

SHANGHAI, China, Aug. 03, 2021 (GLOBE NEWSWIRE) — GDS Holdings Limited (“GDS Holdings,” “GDS” or the “Company”) (NASDAQ: GDS; HKEX: 9698), a leading developer and operator of high-performance data centers in China, today announced that it will report its second quarter 2021 unaudited financial results after the close of the Hong Kong market and before the open of the U.S market on August 17, 2021. The Company’s management will host an earnings conference call at 8:00 AM U.S. Eastern Daylight Time on Tuesday, August 17, 2021 (8:00 PM Hong Kong Time on the same day). Dial-in details for the earnings conference call are as follows:United States: +1-845-675-0437International: +65-6713-5090Hong Kong: +852-3018-6771Mainland China: 400-620-8038Conference ID: 8269683Participants should dial in at least 15 minutes before...

All amounts expressed in US Dollars SANTO DOMINGO, Dominican Republic, Aug. 03, 2021 (GLOBE NEWSWIRE) — Barrick Gold Corporation (NYSE:GOLD) (TSX:ABX) –– Barrick Pueblo Viejo and its key stakeholders have agreed on independent government-led oversight of the strategic environmental and social impact assessment studies for the new tailings storage facility. This facility, which forms part of an expansion project that will require an initial new investment by Pueblo Viejo of $1.3 billion1, is key to the mine continuing to operate beyond 2021 and could extend the Tier One mine’s life to beyond 2040, supporting annual production in excess of 800,000 ounces1. The agreement comes after more than a year of engagement with the communities that could be directly or indirectly affected by the proposed facility and is an important step towards...

DURHAM, N.C., Aug. 03, 2021 (GLOBE NEWSWIRE) — Chimerix (NASDAQ:CMRX), a biopharmaceutical company focused on accelerating the development of medicines to treat cancer and other serious diseases, today announced that Mike Sherman, Chief Executive Officer, will participate in a panel discussion at the 2021 Wedbush PacGrow Healthcare Conference on Tuesday, August 10, 2021 at 10:55 a.m. ET. An audio webcast of the panel discussion will be available on the Investor Relations section of Chimerix’s website at ir.chimerix.com, where it will be archived for approximately 90 days. About Chimerix Chimerix is a development-stage biopharmaceutical company dedicated to accelerating the advancement of innovative medicines that make a meaningful impact in the lives of patients living with cancer and other serious diseases. In June 2021,...

Initial Focus on MEAI Clinical Trial Protocol Toronto, Aug. 03, 2021 (GLOBE NEWSWIRE) —  Clearmind Medicine Inc. (CSE: CMND) (“Clearmind” or the “Company“), a psychedelic medicine biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and undertreated health problems, announces that Mark Haden has joined the Company’s Scientific Advisory Board (the “SAB”). The SAB’s initial focus will be providing guidance on the Company’s request for an Investigational New Drug review from the US Food and Drug Administration (“FDA”) for MEAI, for treating Alcohol Use Disorder (“AUD”). A recognized leader in the field, Mr. Haden has spent his career working to advance the use of psychedelics in medicine. He currently serves as director of clinical research at Psygen Industries,...

Company to Host Quarterly Conference Call at 11:00 AM ET Today WALTHAM, Mass., Aug. 03, 2021 (GLOBE NEWSWIRE) — Great Elm Capital Corp. (“we,” “us,” “our,” or “GECC,”) (NASDAQ: GECC), a business development company, today announced its financial results for the second quarter and six months ended June 30, 2021. Financial and Operating HighlightsNet investment income (“NII”) for the quarter was $2.1 million, as compared to NII of $1.5 million for the quarter ended March 31, 2021, and $0.9 million for the quarter ended June 30, 2020. NII increased quarter-over-quarter due to accelerated deployment of capital during the prior quarter. NII per share was $0.09 based on weighted average shares outstanding of 23,508,232 for the quarter ended June 30, 2021, as compared to NII per share of $0.06, based on weighted average shares outstanding...

REDWOOD CITY, Calif., Aug. 03, 2021 (GLOBE NEWSWIRE) — Rezolute, Inc. (Nasdaq: RZLT), a clinical-stage biopharmaceutical company developing transformative therapies for metabolic diseases related to chronic glucose imbalance, today announced that Nevan Charles Elam, CEO and Founder, will present at two upcoming virtual investment conferences.BTIG Virtual Biotechnology Conference – Tuesday, August 10, 2021 at 12:00 p.m. ET, fireside chat   Canaccord Genuity 41st Annual Growth Conference – Thursday, August 12, 2021 at 3:30 p.m. ET, fireside chatA live webcast of the Canaccord Genuity presentation will be available on the “IR Calendar” page within the Investors section of the Rezolute website at https://ir.rezolutebio.com/ir-calendar. A replay of the webcast will be archived for 90 days following the presentation date. About Rezolute,...

MORRISVILLE, N.C., Aug. 03, 2021 (GLOBE NEWSWIRE) — Liquidia Corporation (NASDAQ: LQDA) announced today that it will report its second quarter 2021 financial results on Tuesday, August 10, 2021. The company will host a webcast and conference call at 8:30 a.m. Eastern Daylight Time to discuss financial results and provide a corporate update. The live call may be accessed by dialing 1-877-707-8711 (domestic) or 1-857-270-6219 (international) and entering the conference code: 4638099. A webcast of the call will be available and archived on Liquidia’s website at https://liquidia.com/index.php/investors/events-and-presentations. About Liquidia CorporationLiquidia Corporation is a biopharmaceutical company focused on the development and commercialization of products in pulmonary hypertension and other applications of its PRINT® Technology....

Global Transformation Efforts Resulted in Constellation Research Award for 2022 ATLANTA, Aug. 03, 2021 (GLOBE NEWSWIRE) — First Advantage (NASDAQ: FA), a leading global provider of technology solutions for screening, verifications, safety, and compliance related to human capital, today shared that the company’s Chief Experience Officer, Joelle Smith, was recently recognized by Constellation Research’s 2022 Business Transformation 150, an elite list of executives who are leading their organization’s business transformation efforts around the globe. With digital leaders significantly challenged by a perfect storm of disruptions due to COVID-19, generational shifts in the workforce, a hypercompetitive customer experience landscape and the relentless march of digital change, among other factors, the BT150 nomination process took these...